OTCMKTS:KNBWY

Kirin Q2 2025 Earnings Results & Report

Kirin logo
$19.61 -0.22 (-1.11%)
As of 01:44 PM Eastern

Kirin missed analyst expectations on both earnings and revenue in its Q2 2025 results, released August 7, 2025. The company reported EPS of $0.24 versus the $0.28 consensus estimate, while revenue of $4.01 billion fell short of the $608.48 billion estimate by $604.47 billion.

Earnings Announcement Details

Quarter
Q2 2025
Report Date
Time
Before Market Opens

Kirin EPS Results

Actual EPS
$0.24
Consensus EPS
$0.28
Beat/Miss
Missed by -$0.04
One Year Ago EPS
N/A
EPS Beat Rate
4 of last 7 quarters

Kirin Revenue Results

Actual Revenue
$4.01 billion
Expected Revenue
$608.48 billion
Beat/Miss
Missed by -$604.47 billion
YoY Revenue Growth
N/A

Conference Call Resources

Kirin Q2 2025 Earnings FAQ

Kirin (OTCMKTS:KNBWY) reported earnings of $0.24 per share for Q2 2025, missing the consensus estimate of $0.28. The report was announced on Thursday, August 7, 2025.

Kirin reported revenue of $4.01 billion for Q2 2025, against a consensus estimate of $608.48 billion.

Kirin Earnings Headlines

Why I'm selling my Snapback Indicator for just $7
For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500. The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long. No strings attached, and Wood says there is an unusual reason behind the steep discount.tc pixel
Kirin (KNBWY) Set to Announce Earnings on Tuesday
See More Kirin Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Kirin? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Kirin and other key companies, straight to your email.

About Kirin

Kirin (OTCMKTS:KNBWY) Holdings Company, Limited is a Japanese company with businesses in beverages, pharmaceuticals and health science. Its beverage operations include beer, wine, spirits, soft drinks and other nonalcoholic products, with brands sold in Japan and international markets.

The company traces its roots to the Japan Brewery Company, established in 1885, and adopted the Kirin Brewery name in 1907. Today, its pharmaceutical business includes Kyowa Kirin, which develops and sells medicines, while its health science activities include products such as supplements and functional foods.

Kirin is headquartered in Tokyo and serves customers across Japan and overseas, including markets in Asia-Pacific and other regions through its operating companies and businesses. Its portfolio spans consumer beverages as well as health-related products and medicines.

View Kirin Profile